Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD : a randomised clinical trial. / Buggeskov, Katrine B; Sundskard, Martin M; Jonassen, Thomas; Andersen, Lars W; Secher, Niels H; Ravn, Hanne B; Steinbrüchel, Daniel A; Jakobsen, Janus C; Wetterslev, Jørn.

In: BMJ Open Respiratory Research, Vol. 3, No. 1, e000146, 2016.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Buggeskov, KB, Sundskard, MM, Jonassen, T, Andersen, LW, Secher, NH, Ravn, HB, Steinbrüchel, DA, Jakobsen, JC & Wetterslev, J 2016, 'Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial', BMJ Open Respiratory Research, vol. 3, no. 1, e000146. https://doi.org/10.1136/bmjresp-2016-000146

APA

Buggeskov, K. B., Sundskard, M. M., Jonassen, T., Andersen, L. W., Secher, N. H., Ravn, H. B., Steinbrüchel, D. A., Jakobsen, J. C., & Wetterslev, J. (2016). Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial. BMJ Open Respiratory Research, 3(1), [e000146]. https://doi.org/10.1136/bmjresp-2016-000146

Vancouver

Buggeskov KB, Sundskard MM, Jonassen T, Andersen LW, Secher NH, Ravn HB et al. Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial. BMJ Open Respiratory Research. 2016;3(1). e000146. https://doi.org/10.1136/bmjresp-2016-000146

Author

Buggeskov, Katrine B ; Sundskard, Martin M ; Jonassen, Thomas ; Andersen, Lars W ; Secher, Niels H ; Ravn, Hanne B ; Steinbrüchel, Daniel A ; Jakobsen, Janus C ; Wetterslev, Jørn. / Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD : a randomised clinical trial. In: BMJ Open Respiratory Research. 2016 ; Vol. 3, No. 1.

Bibtex

@article{bd2c7e1146564d7592f39de6c70cb2b6,
title = "Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial",
abstract = "INTRODUCTION: Absence of pulmonary perfusion during cardiopulmonary bypass (CPB) may be associated with reduced postoperative oxygenation. Effects of active pulmonary artery perfusion were explored in patients with chronic obstructive pulmonary disease (COPD) undergoing cardiac surgery.METHODS: 90 patients were randomised to receive pulmonary artery perfusion during CPB with either oxygenated blood (n=30) or histidine-tryptophan-ketoglutarate (HTK) solution (n=29) compared with no pulmonary perfusion (n=31). The coprimary outcomes were the inverse oxygenation index compared at 21 hours after starting CPB and longitudinally in a mixed-effects model (MEM). Secondary outcomes were tracheal intubation time, serious adverse events, mortality, days alive outside the intensive care unit (ICU) and outside the hospital.RESULTS: 21 hours after starting CPB patients receiving pulmonary artery perfusion with normothermic oxygenated blood had a higher oxygenation index compared with no pulmonary perfusion (mean difference (MD) 0.94; 95% CI 0.05 to 1.83; p=0.04). The blood group had also a higher oxygenation index both longitudinally (MEM, p=0.009) and at 21 hours (MD 0.99; CI 0.29 to 1.69; p=0.007) compared with the HTK group. The latest result corresponds to a difference in the arterial partial pressure of oxygen of 23 mm Hg with a median fraction of inspired oxygen of 0.32. Yet the blood or HTK groups did not demonstrate a longitudinally higher oxygenation index compared with no pulmonary perfusion (MEM, p=0.57 and 0.17). Similarly, at 21 hours there was no difference in the oxygenation index between the HTK group and those no pulmonary perfusion (MD 0.06; 95% CI -0.73 to 0.86; p=0.87). There were no statistical significant differences between the groups for the secondary outcomes.DISCUSSION: Pulmonary artery perfusion with normothermic oxygenated blood during cardiopulmonary bypass appears to improve postoperative oxygenation in patients with COPD undergoing cardiac surgery. Pulmonary artery perfusion with hypothermic HTK solution does not seem to improve postoperative oxygenation.TRIAL REGISTRATION NUMBER: NCT01614951; Pre-results.",
author = "Buggeskov, {Katrine B} and Sundskard, {Martin M} and Thomas Jonassen and Andersen, {Lars W} and Secher, {Niels H} and Ravn, {Hanne B} and Steinbr{\"u}chel, {Daniel A} and Jakobsen, {Janus C} and J{\o}rn Wetterslev",
year = "2016",
doi = "10.1136/bmjresp-2016-000146",
language = "English",
volume = "3",
journal = "B M J Open Respiratory Research",
issn = "2052-4439",
publisher = "B M J Group",
number = "1",

}

RIS

TY - JOUR

T1 - Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD

T2 - a randomised clinical trial

AU - Buggeskov, Katrine B

AU - Sundskard, Martin M

AU - Jonassen, Thomas

AU - Andersen, Lars W

AU - Secher, Niels H

AU - Ravn, Hanne B

AU - Steinbrüchel, Daniel A

AU - Jakobsen, Janus C

AU - Wetterslev, Jørn

PY - 2016

Y1 - 2016

N2 - INTRODUCTION: Absence of pulmonary perfusion during cardiopulmonary bypass (CPB) may be associated with reduced postoperative oxygenation. Effects of active pulmonary artery perfusion were explored in patients with chronic obstructive pulmonary disease (COPD) undergoing cardiac surgery.METHODS: 90 patients were randomised to receive pulmonary artery perfusion during CPB with either oxygenated blood (n=30) or histidine-tryptophan-ketoglutarate (HTK) solution (n=29) compared with no pulmonary perfusion (n=31). The coprimary outcomes were the inverse oxygenation index compared at 21 hours after starting CPB and longitudinally in a mixed-effects model (MEM). Secondary outcomes were tracheal intubation time, serious adverse events, mortality, days alive outside the intensive care unit (ICU) and outside the hospital.RESULTS: 21 hours after starting CPB patients receiving pulmonary artery perfusion with normothermic oxygenated blood had a higher oxygenation index compared with no pulmonary perfusion (mean difference (MD) 0.94; 95% CI 0.05 to 1.83; p=0.04). The blood group had also a higher oxygenation index both longitudinally (MEM, p=0.009) and at 21 hours (MD 0.99; CI 0.29 to 1.69; p=0.007) compared with the HTK group. The latest result corresponds to a difference in the arterial partial pressure of oxygen of 23 mm Hg with a median fraction of inspired oxygen of 0.32. Yet the blood or HTK groups did not demonstrate a longitudinally higher oxygenation index compared with no pulmonary perfusion (MEM, p=0.57 and 0.17). Similarly, at 21 hours there was no difference in the oxygenation index between the HTK group and those no pulmonary perfusion (MD 0.06; 95% CI -0.73 to 0.86; p=0.87). There were no statistical significant differences between the groups for the secondary outcomes.DISCUSSION: Pulmonary artery perfusion with normothermic oxygenated blood during cardiopulmonary bypass appears to improve postoperative oxygenation in patients with COPD undergoing cardiac surgery. Pulmonary artery perfusion with hypothermic HTK solution does not seem to improve postoperative oxygenation.TRIAL REGISTRATION NUMBER: NCT01614951; Pre-results.

AB - INTRODUCTION: Absence of pulmonary perfusion during cardiopulmonary bypass (CPB) may be associated with reduced postoperative oxygenation. Effects of active pulmonary artery perfusion were explored in patients with chronic obstructive pulmonary disease (COPD) undergoing cardiac surgery.METHODS: 90 patients were randomised to receive pulmonary artery perfusion during CPB with either oxygenated blood (n=30) or histidine-tryptophan-ketoglutarate (HTK) solution (n=29) compared with no pulmonary perfusion (n=31). The coprimary outcomes were the inverse oxygenation index compared at 21 hours after starting CPB and longitudinally in a mixed-effects model (MEM). Secondary outcomes were tracheal intubation time, serious adverse events, mortality, days alive outside the intensive care unit (ICU) and outside the hospital.RESULTS: 21 hours after starting CPB patients receiving pulmonary artery perfusion with normothermic oxygenated blood had a higher oxygenation index compared with no pulmonary perfusion (mean difference (MD) 0.94; 95% CI 0.05 to 1.83; p=0.04). The blood group had also a higher oxygenation index both longitudinally (MEM, p=0.009) and at 21 hours (MD 0.99; CI 0.29 to 1.69; p=0.007) compared with the HTK group. The latest result corresponds to a difference in the arterial partial pressure of oxygen of 23 mm Hg with a median fraction of inspired oxygen of 0.32. Yet the blood or HTK groups did not demonstrate a longitudinally higher oxygenation index compared with no pulmonary perfusion (MEM, p=0.57 and 0.17). Similarly, at 21 hours there was no difference in the oxygenation index between the HTK group and those no pulmonary perfusion (MD 0.06; 95% CI -0.73 to 0.86; p=0.87). There were no statistical significant differences between the groups for the secondary outcomes.DISCUSSION: Pulmonary artery perfusion with normothermic oxygenated blood during cardiopulmonary bypass appears to improve postoperative oxygenation in patients with COPD undergoing cardiac surgery. Pulmonary artery perfusion with hypothermic HTK solution does not seem to improve postoperative oxygenation.TRIAL REGISTRATION NUMBER: NCT01614951; Pre-results.

U2 - 10.1136/bmjresp-2016-000146

DO - 10.1136/bmjresp-2016-000146

M3 - Journal article

C2 - 27651908

VL - 3

JO - B M J Open Respiratory Research

JF - B M J Open Respiratory Research

SN - 2052-4439

IS - 1

M1 - e000146

ER -

ID: 167513816